Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Wind

Orthopaedic Surgery Amherst, NY Medical Doctor

NPI 1932179736 CMS profile 132350

4949 Harlem Rd, Amherst, NY 14226

Open in the dashboard

General payments

$109,444

228 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$216,710

4 holdings reported · through program year 2025

Through program year 2025, William Wind of Amherst, NY is reported in the CMS Open Payments database as having received $109,444 across 228 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $216,710 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39,427 32
2024 General $19,454 47
2023 General $5,438 33
2022 General $13,876 25
2021 General $18,902 46
2020 General $361 9
2019 General $11,987 36
2025 Ownership $54,455 1
2024 Ownership $54,455 1
2023 Ownership $54,455 1
2022 Ownership $53,345 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Wind
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Wind were reported at $39,427. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year William Wind Orthopaedic Surgery median Middle half National median
2019 $11,987 $644 $140–$2,844 $163
2020 $361 $312 $75–$1,860 $114
2021 $18,902 $520 $117–$2,495 $132
2022 $13,876 $598 $128–$2,731 $149
2023 $5,438 $461 $128–$2,264 $160
2024 $19,454 $497 $134–$2,475 $164
2025 $39,427 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $96,011 108 payments
  2. Smith+Nephew, Inc. $6,724 56 payments
  3. Prodigy Surgical Distribution, Inc. $5,555 24 payments
  4. Stryker Corporation $345 7 payments
  5. Ferring Pharmaceuticals Inc. $215 11 payments
  6. Flexion Therapeutics, Inc. $131 6 payments
  7. FX Shoulder USA, Inc $125 1 payment
  8. Bioventus LLC $79 3 payments
  9. LifeNet Health $61 1 payment
  10. AxoGen $49 1 payment
  11. Other $148 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $88,085 14 payments
  2. Travel and Lodging $11,464 43 payments
  3. Food and Beverage $8,000 170 payments
  4. Education $1,895 1 payment
Products named General payments · program years 2019–2025
  1. HEALICOIL Sports Med Shoulder $1,394 6 payments
  2. Bone Anchors with Arthroscopic Delivery System $891 3 payments
  3. Bioinductive Implant with Arthroscopic Delivery System - Medium $847 7 payments
  4. SPATIAL FRAME $813 4 payments
  5. NovoStitch $731 1 payment
  6. JOURNEY II XR $643 2 payments
  7. ENDOBUTTON $605 3 payments
  8. REGENETEN $499 3 payments
  9. HEALICOIL Sports Med Shoulder $393 1 payment
  10. Q-FIX $392 2 payments
  11. Other $5,999 109 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

25

Median for Orthopedic Surgery: 203

Drug cost

$91

Median for Orthopedic Surgery: $1,433

Branded share of claims

100%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 25 $91

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$10,424

Medicare's payments for the services billed

Medicare patients

100

Average age 67

Services billed

179

50 women, 50 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 64%
Diabetes 26%
Chronic kidney disease 26%
Depression 23%
Ischemic heart disease 22%
Cancer 16%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

228 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record